Clinical trial Recruiting at 5 sites Interventional Ages Any age to 30 Weeks

Determining the best time to stop CPAP for premature infants

Official title: Flow and Grow - A CPAP Management Strategy for Preterm Infants to Support Lung Growth. A Randomized, Prospective, Multi-center Study

Run by University of California, San Diego · NCT06123143 · Data updated 2026-11-12

This study is testing the best time to stop using CPAP for premature babies born very early to see if it helps them breathe better and stay healthy.

Quick facts

Study typeInterventional
AgesAny age to 30 Weeks
SexAll
Enrollment130 (estimated)
SponsorUniversity of California, San Diego
Academic / other
Locations5 sites (Escondido, California and 4 other locations)
StatusRecruiting
StartedNovember 27, 2023
Main results expectedNovember 2028
Study endsNovember 2028
Registry record updatedJanuary 20, 2026
Trial IDNCT06123143 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are infants born at less than 30 weeks gestational age who are admitted to participating NICUs.

Probably not a fit

Patients with congenital anomalies or complications requiring long-term support, or those intubated for over 28 days, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the optimal timing for weaning Continuous Positive Airway Pressure (CPAP) in extremely low birth weight infants born before 30 weeks of gestation. It is a multicenter, non-blinded, randomized control trial conducted across four Neonatal Intensive Care Units (NICUs) within the Rady Children's/University of California, San Diego network. The study aims to recruit 130 infants and will compare the duration of respiratory support and oxygen exposure between those following a structured weaning protocol and those weaned earlier. The goal is to reduce CPAP weaning failure rates and improve outcomes for these vulnerable infants.

Why it matters

Potential benefit: If successful, this study could lead to improved respiratory outcomes and reduced rates of chronic lung disease in premature infants.

How similar studies have gone: Previous studies have indicated that delaying CPAP weaning can significantly reduce failure rates, suggesting that this approach may be beneficial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. All infants admitted to the NICU at Jacobs, Rancho Springs, Scripps La Jolla, Rady Children's Hospital, or Palomar born at \< 30 weeks CGA
2. Informed parental consent obtained

Exclusion Criteria:

1. Declined or unable to give informed consent
2. Infants with known congenital anomalies or complications that require long term support (pulmonary hypoplasia, airway defects, genetic syndromes, necrotizing enterocolitis (NEC), spontaneous intestinal perforation (SIP), anything surgical)
3. Intubated for over 4 weeks of life (28 days)

Where it's running

  • Palomar Medical Center Rady NICU
    Escondido, California, United States
    Recruiting
  • Scripps La Jolla Rady NICU
    La Jolla, California, United States
    Recruiting
  • University of California, San Diego Jacobs Medical Center
    La Jolla, California, United States
    Recruiting
  • Rancho Springs Medical Center Rady NICU
    Murrieta, California, United States
    Recruiting
  • Rady Children's Hospital-San Diego
    San Diego, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.